DailyIQ
DailyIQ
Last updated1 minute ago

MRSH·Marsh

$204.82
-4.61 (-2.20%)
After Hours
High
$209.43
Open
$202.35
Market Cap
98.59B
52W High
$214.00
Low
$202.35
P. Close
$204.82
P/E
24.40
52W Low
$156.60
Fwd P/E
17.87
DailyIQ Est.
$207.24
Inst. Own.
76.8%
Short Interest
1.40%
Days to Cover
2.4
Div. Yield
1.85%
Next Ex-Div
~Dec 28
Div. Growth
16+ yrs
NewEarnings release, scored · filed Oct 15, 2026tone -1.6 vs prior release · 47 lines scoredSee the breakdown
Technical Score (1D)
39
BEARISH
News Sentiment
60
BULLISH
On Nov 4, Marsh & McLennan Companies completed its acquisition of AltamarCAM, adding a specialist private‑markets asset manager to its portfolio and increasing its private‑markets assets under management to $75 billion. The transaction broadened Marsh’s capabilities in secondaries, co‑investments, bespoke accounts and evergreen vehicles, strengthening its services for insurers, family offices, pension funds and banks across Europe and Latin America. On the same day, Marsh launched Marsh BrightPath, a fee‑based private‑markets and retirement platform that is expected to support long‑term cash‑flow durability and improve capital efficiency. Analysts reported that the AltamarCAM deal and the BrightPath launch could enhance Marsh’s long‑term earnings prospects, suggesting the stock may be undervalued by up to 27 percent. Both reports highlighted how the acquisitions and new platform expand Marsh’s fee‑based exposure and institutional client base, underscoring the strategic importance of the deal for the company’s future growth.
LOW TARGET
$180 -12.1%
2 analysts
MEAN TARGET
$207 +0.9%
23 analysts
HIGH TARGET
$230 +12.3%
7 analysts
PRICE RANGE
$180.00 - $230.00
SB / B / H / S / SS
3/9/18/1/1
DAILYIQ EST.
$207.24 (+1.2%)
Sector
Financial Services
Industry
Insurance Brokers
Exchange
NYQ
Country
United States
Symbol
MRSH
Description
Marsh & McLennan Companies is a global professional services firm specializing in risk, strategy, and people-related advisory and insurance solutions. The company operates through two primary segments: Risk and Insurance Services, and Consulting. Its Risk and Insurance Services segment offers a comprehensive suite of risk management services, including risk assessment, transfer, and mitigation strategies, alongside insurance and reinsurance brokerage. The Consulting segment provides expert advice and solutions related to health, wealth, career, and specialized management consulting. Serving a diverse clientele that includes businesses, public entities, and insurance companies, Marsh & McLennan has a long-standing history, having been founded in 1871, and is headquartered in New York City.
Bought (1Y)
0 shares
$0
Sold (1Y)
68,109.39 shares
$12.4M
Tomlinson PatrickPres/CEO, Marsh People & Inv
Option Exercise2,500 shares2026-11-02
Tomlinson PatrickPres/CEO, Marsh People & Inv
Tax Withholding1,775 shares2026-11-02
Tomlinson PatrickPres/CEO, Marsh People & Inv
Option Exercise2,500 shares2026-11-02
Mills StacyVice President and Controller
Sell1,215 shares2026-10-23
Klisura Dean MichaelPresident & CEO, Marsh RE
Sell4,194 shares2026-10-23
71/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
15.4%
Revenue CAGR
5.0%
Current Ratio
1.10x
Debt / Equity
1.28x
Return on Equity
27.2%
Earnings Summary
In the latest reporting period, the company posted Q3 2026 revenue of $6.86 bn versus an estimate of $6.77 bn, and EPS of $2.03 versus an estimate of $2.01, both beating expectations; the company’s revenue grew from $7.07 bn in Q1 2025 to $7.60 bn in Q1 2026, and then slightly declined to $7.40 bn in Q2 2026 before rising to $6.86 bn in Q3 2026, indicating a modest YoY revenue increase of about 3% in 2026. Historically, Marsh & McLennan has maintained a steady earnings trajectory, beating EPS estimates in 3 of the last 4 quarters and showing consistent fee growth, with revenue growth persisting despite modest quarterly fluctuations. Recent news includes the acquisition of Triton Insurance Agency to broaden marine and yacht insurance offerings, and the issuance of €1.2 bn of senior notes to refinance debt, both aimed at strengthening the firm’s balance sheet and expanding market reach.

EPS

EstBeatMiss
$1.82$2.24$2.65$3.07$3.48Q1'25Q1'26Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$2.26 - -
Q3'26$2.01$2.03+0.8%
Q2'26$2.89$2.96+2.3%
Q1'26$3.29$3.29-0.0%
Q1'25$3.00$3.06+2.1%

Revenue

EstBeatMiss
$6.6B$6.9B$7.2B$7.5B$7.7BQ1'25Q1'26Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$7.0B - -
Q3'26$6.8B$6.9B+1.3%
Q2'26$7.4B$7.4B-0.3%
Q1'26$7.6B$7.6B+0.5%
Q1'25 - $7.1B -

Market Data

MRSH Stock Snapshot

NEUTRAL39/100
$204.82+$0.00 (0.0%)
Market cap
98.59B
P/E ratio
24.4
Day range
$202.35 – $209.43
News sentiment
60/100 · Bullish
Analyst target
$206.62 (+0.9%)
Consensus
Hold · 32 analysts
52-week range+30.8% off low · -4.3% from high
$156.60$214.00
Price $204.82 DailyIQ Est. $207.24

Momentum has flattened on MRSH, leaving the next move dependent on news rather than the chart. Sector peers are worth watching - large caps in Financial Services tend to move together on rotation.

Behaviour On Record

What MRSH's own history says about today's numbers

Realized volatility (21d)
31.7% 93rd pct
Below its peak
-21.2%
vs 200-day average
+15.3%
Up days (1y)
49%

Marsh is currently running 31.7% annualised volatility over the last 21 sessions. Measured against MRSH's own 13 years of daily returns rather than a market-wide average, that is the 93rd percentile — an extreme by its own standards, against a typical reading of 16.3%.

MRSH is trading -21.2% below its running peak. Across 13 full years on file, its median worst-drawdown-in-a-year was -12.3%, and the deepest was -35.8% in 2020. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began, and where past declines also continued.

Price sits +15.3% from its 200-day moving average. Against every other day in its history, that gap ranks at the 94th percentile — a wider gap than this stock usually carries. Over the past year MRSH closed higher on 49% of sessions, and it is currently 2 sessions into a falling streak.

On November specifically: over 13 years of records, MRSH finished the month higher 12 of 13 times, with a median return of +3.6% and an average of +4.3%. Its strongest month historically has been November at +4.3% on average, its weakest September at -2.0%.

Overnight risk is measurable too: MRSH has opened more than 2% away from the prior close in 75 of 3,267 sessions (2.3% of the time), with the largest gaps running +25.0% and -16.5%.

Across the last 3 dated reports on file, MRSH moved an average of 2.2% in the session after earnings, closing higher 1 of those 3 times, with a median move of -2.4% and a largest of -3.3%.

All figures computed from 3,268 daily closes between 2013-11-08 and 2026-11-06, split-adjusted, recomputed daily. Percentiles are against MRSH's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of MRSH's sector?

Marsh sits in the Financials sector, currently ranked 6th of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Insurance industry group, MRSH ranks 4th of 15 tracked industries, leading.

Sector rank
#6 of 12
Sector state
Leading
Sector rotation score
64
Industry rank
#4 of 15

Options Market

What is the options market pricing for MRSH?

CallsPuts

For Marsh's nearest expiry (2026-11-20, 13 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 2.56), with at-the-money implied volatility around 45.7%. The options market is pricing roughly a ±7.4% move by that expiry — a range of about $181.13–$209.99.

Put/call ratio (2026-11-20)
2.56
ATM implied volatility
45.7%
Total open interest
5,212
Expected move by 2026-11-20
±7.4% ($181.13–$209.99)

Analyst Consensus Estimates

What do analysts expect MRSH to earn?

Analysts expect Marsh to earn $10.49 per share in the fiscal year ending Dec 2026 and $12.34 in the fiscal year ending Dec 2028, from 8 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.

Quarter endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026$2.22$2.12 to $2.2821$6.91B12
Mar 2027$3.57$3.47 to $3.6820$7.95B10
Jun 2027$3.19$3.01 to $3.297~$8.42B-
Sep 2027$2.23$2.10 to $2.387~$5.89B-
Fiscal year endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026$10.49$10.39 to $10.5823$28.74B16
Dec 2027$11.46$10.96 to $11.7623$30.14B15
Dec 2028$12.34$11.70 to $12.828~$32.57B-

Revenue marked ~ is our calculation from the EPS estimate, not analyst consensus.

Analyst Rating Changes

Are analysts turning bullish or bearish on MRSH?

BMO Capital most recently upgraded Marsh to Outperform on Nov 3, 2026 with a price target of $230 (from $204). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.

Latest action
BMO Capital: Outperform
90-day upgrades
1
90-day downgrades
0
Net rating momentum
+1
DateFirmActionRatingPrice target
Nov 3, 2026BMO CapitalUpgradeMarket Perform → Outperform$204 → $230
Oct 20, 2026JP MorganMaintainedOverweight$215 → $218
Oct 19, 2026MizuhoMaintainedNeutral$190 → $200
Oct 19, 2026Keefe, Bruyette & WoodsMaintainedMarket Perform$186 → $201
Oct 16, 2026CitigroupMaintainedNeutral$200 → $203
Oct 16, 2026Wells FargoMaintainedEqual-Weight$183 → $197
Oct 12, 2026Wells FargoMaintainedEqual-Weight$188 → $183
Oct 7, 2026MizuhoMaintainedNeutral$201 → $190
Oct 6, 2026Morgan StanleyMaintainedEqual-Weight$200 → $180
Oct 6, 2026UBSMaintainedBuy$216 → $222
Oct 1, 2026JP MorganMaintainedOverweight$212 → $215
Aug 19, 2026Morgan StanleyMaintainedEqual-Weight$180 → $200

Earnings Release, Scored

What did Marsh's latest earnings release say?

Filed Oct 15, 2026 · SEC Form 8-K, Exhibit 99

Tone81.5/ 100-1.6 vs prior release
Hedging words0.96per 100 words-0.01 vs prior release
Tone, last 2 releasesScale 50–89

Most important lines

  1. 1

    John Doyle, President and CEO, said: "Marsh delivered a strong third quarter, generating 5% underlying revenue growth and double-digit EPS growth.

    New this quarter
  2. 2

    For the nine months ended September 30, 2026, Reinsurance's revenue decreased 1% on an underlying basis.

    New this quarterNegative tone
  3. 3

    Investments and Retirement revenue grew 8%, Health and Benefits revenue increased 5%, and Workforce and Rewards revenue decreased 1%, all on an underlying basis.

    New this quarter

Peers & ETF holders

MRSH peers & ETF holders

News & sentiment

What is the news saying about MRSH?

MRSH rose 19.3% over the month to Nov 6. News tone held between 47 and 67 from Oct 6 to Oct 21, then dropped to 37 on Oct 26.

Daily close and news tone, Oct 6 to Nov 6
$180$200Oct 6: tone 67Oct 7: tone 47Oct 8: tone 51Oct 9Oct 12: tone 54Oct 13: tone 54Oct 14: tone 57Oct 15: tone 66Oct 16: tone 65Oct 19: tone 64Oct 20: tone 55Oct 21: tone 57Oct 22Oct 23Oct 26: tone 37Oct 27: tone 50Oct 28: tone 64Oct 29: tone 50Oct 30Nov 2: tone 66Nov 3: tone 71Nov 4: tone 76Nov 5: tone 63Nov 6Oct 6News toneNov 6123
  1. Oct 15 +4.6%same day: Marsh: Q3 Earnings Snapshot
  2. Oct 22 +4.9%
  3. Oct 29 +4.0%

Technical analysis

How strong is MRSH's momentum right now?

On the daily chart MRSH ranks at the 39th percentile for momentum against 1,060 stocks and ETFs, a neutral reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling MRSH?

92 of the 224 tracked managers added to MRSH in their latest 13F and 130 trimmed. Together they own 76.8% of the company, worth $61.8B. BlackRock and Vanguard Capital Management alone hold 14.7%.

92adding130trimming2unchanged
Largest holders by stake, latest 13FBar = share of MRSH
  1. $6.6B positionTrimmed 6.1% last quarter
  2. $5.2B positionAdded 0.0% last quarter
  3. $3.7B positionAdded 1.5% last quarter
  4. $3.0B positionAdded 0.9% last quarter
  5. $2.8B positionTrimmed 2.3% last quarter
  6. $2.6B positionAdded 0.1% last quarter
  7. $2.1B positionAdded 1.1% last quarter
  8. $2.1B positionTrimmed 10.7% last quarter
  9. $1.8B positionTrimmed 2.9% last quarter
  10. $1.4B positionAdded 68.1% last quarter
Full holdings history

Congressional trading

Is Congress trading MRSH?

5 members of Congress disclosed 11 MRSH trades between Oct 29, 2024 and Sep 23, 2026: 1 buy and 10 sells, about $623.0K in estimated value.

BuysSellsJan ’25MaySepJan ’26MaySep
BuySell$1K–$15K$15K–$50K$50K–$100K$100K–$250K

What stands out

Click one to highlight its trades in the chart

Discover more

How has MRSH done against its peers?

Over the six months to Nov 6, MRSH returned +25.0%. Of the 15 related stocks and ETFs, 1 did better, led by MA at +32.7%.

Change since May 6, through Nov 6
−20%0%+20%+40%May 6JunJulAugSepOctNov 6MA +32.7%MRSH +25.0%BAC −7.6%